Navigation Links
HumanZyme® Launches New XKine™ Recombinant Protein Line Expanding Reagents For Stem Cell Research and Regenerative Medicine Applications
Date:6/1/2016

HumanZyme Inc., a leading supplier of novel human proteins and growth factors to academic and biopharmaceutical customers enabling stem cell research and regenerative therapy applications, today announced the launch of the new XKine™ product line broadening the company's product offering. The new XKine human recombinant proteins are manufactured utilizing E.coli, Insect, or Chinese Hamster Ovary (CHO) host cell lines, expanding the number of research applications supported by HumanZyme.

“The new XKine products are priced competitively and selected carefully to support current pathway analysis, allowing our customers to purchase these products from HumanZyme, without the need to go to a 3rd party supplier as previously required,” said Scott Coleridge, CEO at HumanZyme. The new XKine recombinant human protein line includes Activin-B, Adiponectin, IL-1 alpha, INF-gamma, INF-beta, IL-5, IL8(CxXL8), IL-11, IL-15, IL-13, IL-16, IL-17b/d/e, IL-34, IL35, DKK, CT-1, IGF-1, Neurturin, PDGF-BB, Rantes(CCL5), sCD40 ligand, sTrail/apo2L, BDNF, GDNF, CTGF, EGF, FGF-basic, LIF, BMP-3, BMP-5, BMP-13, Prolactin, Relaxin 2, TNF-beta, Sonic Hedgehog, and FGF-acidic.

For more information, see our list of new XKine products.

About HumanZyme, Inc.

HumanZyme, Inc. is the global leader in providing highly authentic recombinant human proteins from human cells. Our process is cost-effective and scalable making our proteins suitable for the research, diagnostic, drug discovery and biopharmaceutical markets. HumanZyme leverages its proprietary engineered human cells, expression vector, and cell culture media to ensure high-yield production of recombinant proteins with native human post-translational modifications, such as disulfide bonds and glycosylation. We are a leading provider of cytokines and growth factors and a preferred outsourcing supplier of human protein production. Our products and services support a broad range of customers worldwide—from academic and government research institutions to biotechnology and pharmaceutical companies. For more information, visit http://www.humanzyme.com.

Read the full story at http://www.prweb.com/releases/humanzyme/XKine/prweb13452218.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related biology technology :

1. Acumed Launches New State-of-the-Art System for Ankle Fractures
2. Fluence Bioengineering Launches New LED-Based Horticulture Lighting Systems
3. Meister Media Worldwide Launches New Website
4. Connecticut Innovations Launches $5 Million Global Investment Challenge
5. SFARI Launches SPARK, Nations Largest Research Initiative for Parents, Children and Adults with Autism
6. Proove Biosciences Launches Expanded Drug Metabolism Profile to Help Doctors Prescribe Heart Medications with Greater Precision
7. Human Vaccines Project Launches San Diego Research Hub with UC San Diego, J. Craig Venter Institute, La Jolla Institute, The Scripps Research Institute
8. Cirrascale® Launches Innovative Multi-GPU Cloud Service Aimed at Tackling Multi-GPU Deep Learning Training Applications
9. BioGenex Launches Two New Antibodies for Cancer Diagnosis
10. EarlySense Launches New Multi-Parameter Alert to Support Hospital Sepsis Protocol
11. LifeTein Launches Rush Custom Peptide Synthesis Service: Peptide Delivered in 3-5 Days
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/19/2019)... , ... July 18, 2019 , ... ... announced their investment to enlarge their current piezo motion facilities in Lederhose, Germany, ... 3 floors for multilayer piezo ceramic assembly production in addition to general office ...
(Date:7/17/2019)... ... July 16, 2019 , ... ... a recent report from Kalorama Information. Abbott, Roche and Siemens Healthineers and Response ... Information’s latest report, Worldwide Market for Point-of-Care (POC) Diagnostics . , Quidel ...
(Date:7/2/2019)... ... 02, 2019 , ... Leading Regenerative Veterinary Medicine company, VetStem Biopharma , ... The film focuses on regenerative veterinary medicine as a means of improving the ... included in the Brentwood and Pacific Palisades International Film Festival in Los Angeles, ...
(Date:6/12/2019)... ... June 12, 2019 , ... ... testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries, is ... signed. The agreement will grant exclusive rights for Zillion to represent LDA in ...
Breaking Biology Technology:
(Date:7/26/2019)... ... 25, 2019 , ... Lemnis Technologies, the technology company behind ... a new generation eye tracker with hassle-free calibration. The headsets will be demonstrated ... - August 1). SIGGRAPH attendees will be able to try Verifocal™ headsets in ...
(Date:7/23/2019)... ... July 22, 2019 , ... Personalized Stem Cells, Inc (“PSC”), a human ... for use of a person’s own adipose-derived stem cells to treat their osteoarthritis. The ... of osteoarthritis in the knee. , This is the first of several ...
(Date:7/19/2019)... POWAY, Calif. (PRWEB) , ... July 18, 2019 , ... ... with clinical, regulatory and manufacturing experience. As a result of a two-year ... to commercialize the Calidi oncolytic virus platform in veterinary medicine. VetStem should be ...
Breaking Biology News(10 mins):